Serious pneumococcal infections are a major global health problem and are vaccine-preventable.

Serious pneumococcal infections are a major global health problem and are vaccine-preventable.

Pneumo Slide Set

First Edition (January 2008)

Chapter 1: What is the Pneumococcus?
  • Bacteriology
  • The biological relevance of pneumococcal serotypes
  • The progression of pneumococcal disease
  • Disease transmission
  • Clinical syndromes
  • Risk factors
Download Chapter 1: What is the Pneumococcus? [9.9 MB]


Chapter 2: Diagnosis Treatment & Prevention
  • Methods of diagnosis
  • Treatment
  • The rise of antibiotic resistance
  • Challenges to the effective treatment of pneumococcal disease
  • The Cost of Illness
  • Prevention of pneumococcal disease
Download Chapter 2: Diagnosis Treatment & Prevention [18.5 MB]


Chapter 3: Pneumococcal Conjugate Vaccines
  • Immune response to Pneumococcus
  • Types of pneumococcal vaccines
  • Pneumococcal conjugate vaccine (PCV) safety
  • PCV immunogenicity
  • PCV efficacy
  • PCV impact
  • Potential impact of PCV in low-income countries
Download Chapter 3: Pneumococcal Conjugate Vaccines [3.7 MB]


Chapter 4: Preventing Pneumonia & Pneumococcal Disease: The Way Forward
  • Time lag for vaccines reaching the developing world
  • About the GAVI Alliance and PneumoADIP
  • Pneumococcal vaccine is an effective live-saving intervention
  • Vaccine supply and demand
  • Demand for pneumococcal vaccine
  • Funding for pneumococcal vaccine
  • Procuring pneumococcal vaccine
  • The way forward
Download Chapter 4: Preventing Pneumonia & Pneumococcal Disease [5.6 MB]


Special thanks to the technical reviewers who contributed to the development of this slide set:
Dr. Steven Black
Dr. Thomas Cherian
Dr. Adam Finn
Ms. Linda Glennie
Dr. Adenike Grange
Dr. Sheldon Kaplanv
Dr. Keith P. Klugman
Dr. Samir Saha
Ms. Denise Vaughan

Editors:
Meenakshi Ramakrishnan MD, MPH
Michelle Moncrieffe Foreman MA

If you have any comments or feedback about the contents of this the pneumococcal disease slide set, please email: pneuadip@jhsph.edu.

The Pneumococcal vaccines Accelerated Development and Introduction Plan is based
at Johns Hopkins Bloomberg School of Public Health and is funded by GAVI Alliance.